Research advances in pharmacotherapy for autoimmune hepatitis / 临床肝胆病杂志
Journal of Clinical Hepatology
;
(12): 915-921, 2023.
Article
in Chinese
| WPRIM
| ID: wpr-971851
ABSTRACT
Autoimmune hepatitis (AIH) is an immune-mediated chronic inflammatory liver disease. At present, standard treatment is effective in most AIH patients, and second- or third-line pharmacotherapy can be selected for patients who have suboptimal response to standard treatment or cannot tolerate the side-effects of the drugs. Novel therapies are undergoing clinical trials with the further exploration of the pathogenesis of AIH. This article reviews the current research advances in pharmacotherapy for AIH.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of Clinical Hepatology
Year:
2023
Type:
Article
Similar
MEDLINE
...
LILACS
LIS